CYTKHealthcareMid-Cap

CYTOKINETICS INC Insider Trading Activity

Every SEC Form 4 insider transaction reported for CYTOKINETICS INC (CYTK), sourced directly from SEC EDGAR and updated as new filings are accepted.

Last updated:

Quick Answer

Are CYTK insiders buying or selling?

CYTOKINETICS INC insiders reported 2 open-market buys ($3.3M) and 409 sells ($174.7M) across 411 Form 4 filings — a net selling position of $171.4M.

Source: SEC EDGAR Form 4

Key Statistics (as of Sep 1, 2026)

Total Form 4 filings
411
SEC EDGAR
Insider filers
20
Insider buys (2)
$3.3M
Insider sells (409)
$174.7M

Insider sentiment

Net selling

Net insider flow of $171.4M in net selling.

Recent CYTK insider transactions

DateInsiderRoleTypeSharesPriceValue
Sep 1, 2026Lynne B ParshallDirectorSale5.0K$71.48$357.4K
Aug 31, 2026Andrew CallosEVP, Chief Commercial OfficerSale10.0K$70.24$702.4K
Aug 31, 2026Robert I BlumPresident & CEOSale7.5K$70.24$526.8K
Aug 18, 2026Fady Ibraham MalikEVP Research & DevelopmentSale3.5K$75.82$265.4K
Aug 10, 2026Robert I BlumPresident & CEOSale7.5K$76.76$575.7K
Jul 30, 2026Andrew CallosEVP, Chief Commercial OfficerSale14.0K$79.88$1.1M
Jul 27, 2026Robert I BlumPresident & CEOSale7.5K$80.87$606.5K
Jul 23, 2026Fady Ibraham MalikEVP Research & DevelopmentSale3.5K$80.59$282.1K
Jul 14, 2026Robert I BlumPresident & CEOSale7.5K$82.02$615.1K
Jul 7, 2026Fady Ibraham MalikEVP Research & DevelopmentSale3.5K$86.62$303.2K
Jul 2, 2026Robert I BlumPresident & CEOSale7.5K$84.92$636.9K
Jul 2, 2026Andrew CallosEVP, Chief Commercial OfficerSale15.0K$85.80$1.3M
Jul 2, 2026Sung LeeEVP, Chief Financial OfficerSale1.1K$87.79$97.6K
Jun 29, 2026Sung LeeEVP, Chief Financial OfficerSale38.7K$82.30$3.2M
Jun 29, 2026Sung LeeEVP, Chief Financial OfficerSale3.1K$85.00$266.4K
Jun 23, 2026Fady Ibraham MalikEVP Research & DevelopmentSale3.5K$79.51$278.3K
Jun 15, 2026Robert I BlumPresident & CEOSale7.5K$70.46$528.5K
Jun 9, 2026Fady Ibraham MalikEVP Research & DevelopmentSale3.5K$67.98$237.9K
Jun 1, 2026Edward M. Kaye MDDirectorSale2.9K$76.09$223.2K
Jun 1, 2026Andrew CallosEVP, Chief Commercial OfficerSale15.0K$74.08$1.1M
Jun 1, 2026Lynne B ParshallDirectorSale5.0K$74.08$370.4K
May 28, 2026Robert I BlumPresident & CEOSale7.5K$77.21$579.1K
May 20, 2026Fady Ibraham MalikEVP Research & DevelopmentSale3.5K$75.69$264.9K
May 14, 2026Robert I BlumPresident & CEOSale7.5K$77.92$584.4K
May 5, 2026Fady Ibraham MalikEVP Research & DevelopmentSale3.5K$77.37$270.8K

Showing the 25 most recent of 411 Form 4 filings for CYTOKINETICS INC.

Most active CYTK insiders

  • Robert I Blum145 filings
  • Fady Ibraham Malik115 filings
  • Andrew Callos29 filings
  • Lynne B Parshall17 filings
  • Sandford D Smith17 filings

Ask anything about CYTK insider activity

Use Trabud's AI agent to query CYTOKINETICS INC's Form 4 history in plain English — "Show me CYTK CEO purchases this year" or compare it against any other ticker.

Open the AI agent

CYTK insider trading FAQ

Are CYTOKINETICS INC insiders buying or selling?

Across 411 SEC Form 4 filings, CYTOKINETICS INC (CYTK) insiders reported 2 open-market purchases totaling $3.3M and 409 sales totaling $174.7M. That is a net selling position of $171.4M.

How many insiders trade CYTK stock?

20 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for CYTOKINETICS INC. The most recent filing was accepted on Sep 1, 2026.

Where does Trabud get CYTK insider trading data?

All CYTK insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.

Looking for another company? Browse all tracked companies.

Related Content